{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:52:42Z","timestamp":1793159562134,"version":"4.5.0"},"reference-count":126,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Netherlands Heart Foundation"},{"name":"CVON DOSIS","award":["2014-40"],"award-info":[{"award-number":["2014-40"]}]},{"name":"CVON SHE-PREDICTS-HF"},{"name":"CVON RED-CVD","award":["2017-11"],"award-info":[{"award-number":["2017-11"]}]},{"name":"Innovational Research Incentives Scheme"},{"name":"Netherlands Organization for Scientific Research","id":[{"id":"https:\/\/ror.org\/04jsz6e67","id-type":"ROR","asserted-by":"crossref"}]},{"name":"NWO VIDI","award":["917.13.350"],"award-info":[{"award-number":["917.13.350"]}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC CoG 818715"],"award-info":[{"award-number":["ERC CoG 818715"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,15]]},"DOI":"10.1093\/cvr\/cvz035","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T15:53:27Z","timestamp":1549036407000},"page":"844-853","source":"Crossref","is-referenced-by-count":290,"title":["Common risk factors for heart failure and cancer"],"prefix":"10.1093","volume":"115","author":[{"given":"Wouter C","family":"Meijers","sequence":"first","affiliation":[{"name":"University Medical Centre Groningen, University of Groningen, Department of Cardiology, Hanzeplein 1, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A","family":"de Boer","sequence":"additional","affiliation":[{"name":"University Medical Centre Groningen, University of Groningen, Department of Cardiology, Hanzeplein 1, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/ehx628","article-title":"European Society of Cardiology: cardiovascular Disease Statistics 2017","volume":"39","author":"Timmis","year":"2018","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B3","doi-asserted-by":"crossref","first-page":"e005231.","DOI":"10.1161\/JAHA.116.005231","article-title":"Risk for incident heart failure: a subject-level meta-analysis from the heart \u2018OMics\u2019 in AGEing (HOMAGE) study","volume":"6","author":"Jacobs","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15256\/joc.2014.4.41","article-title":"Competing risks of cancer mortality and cardiovascular events in individuals with multimorbidity","volume":"4","author":"Bayliss","year":"2014","journal-title":"J Comorb"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B5","doi-asserted-by":"crossref","first-page":"597.","DOI":"10.1186\/s12885-017-3557-1","article-title":"Cancer-related risk factors and incidence of major cancers by race, gender and region; analysis of the NIH-AARP diet and health study","volume":"17","author":"Akinyemiju","year":"2017","journal-title":"BMC Cancer"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B6","doi-asserted-by":"crossref","first-page":"k134.","DOI":"10.1136\/bmj.k134","article-title":"Cancer risk associated with chronic diseases and disease markers: prospective cohort study","volume":"360","author":"Tu","year":"2018","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/20009666.2016.1264696","article-title":"Prevalence and risk factors of heart failure in the USA: NHANES 2013\u20132014 epidemiological follow-up study","volume":"7","author":"Komanduri","year":"2017","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B8","doi-asserted-by":"crossref","first-page":"e003116.","DOI":"10.1161\/CIRCHEARTFAILURE.115.003116","article-title":"Predicting heart failure with preserved and reduced ejection fraction","volume":"9","author":"Ho","year":"2016","journal-title":"Circ Hear Fail"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/ejhf.1091","article-title":"Predictors and outcomes of heart failure with mid-range ejection fraction","volume":"20","author":"Bhambhani","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B10","doi-asserted-by":"crossref","first-page":"e000222.","DOI":"10.1136\/openhrt-2014-000222","article-title":"Clinical prediction of incident heart failure risk: a systematic review and meta-analysis","volume":"2","author":"Yang","year":"2015","journal-title":"Open Hear"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/CIRCHEARTFAILURE.114.001896","article-title":"Population risk prediction models for incident heart failure","volume":"8","author":"Echouffo-Tcheugui","year":"2015","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11897-012-0115-7","article-title":"Comparing new onset heart failure with reduced ejection fraction and new onset heart failure with preserved ejection fraction: an epidemiologic perspective","volume":"9","author":"Brouwers","year":"2012","journal-title":"Curr Heart Fail Rep"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamacardio.2018.1717","article-title":"Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK Biobank Study","volume":"3","author":"Said","year":"2018","journal-title":"JAMA Cardiol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ijcard.2016.11.061","article-title":"The LifeLines Cohort Study: prevalence and treatment of cardiovascular disease and risk factors","volume":"228","author":"van der Ende","year":"2017","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B15","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B16","doi-asserted-by":"crossref","first-page":"66.","DOI":"10.1001\/jama.2013.7588","article-title":"Natriuretic peptide-based screening and collaborative care for heart failure","volume":"310","author":"Ledwidge","year":"2013","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jacc.2013.05.069","article-title":"PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial","volume":"62","author":"Huelsmann","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B18","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.293.11.1338","article-title":"Effects of long-term vitamin e supplementation on cardiovascular events and cancer","volume":"293","author":"Lonn","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1809944","article-title":"Vitamin D supplements and prevention of cancer and cardiovascular disease","volume":"380","author":"Manson","year":"2019","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B20","doi-asserted-by":"crossref","first-page":"e000653.","DOI":"10.1136\/bmjopen-2011-000653","article-title":"Cancer risk with folic acid supplements: a systematic review and meta-analysis","volume":"2","author":"Wien","year":"2012","journal-title":"BMJ Open"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/CIRCULATIONAHA.118.033603","article-title":"Linking heart failure to cancer\u2014background evidence and research perspectives","volume":"138","author":"Bertero","year":"2018","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCULATIONAHA.118.033907","article-title":"Heart disease and cancer","volume":"138","author":"Kitsis","year":"2018","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jacc.2013.04.088","article-title":"Patients with heart failure have an increased risk of incident cancer","volume":"62","author":"Hasin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B25","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.117.030816","article-title":"Heart failure stimulates tumor growth by circulating factors","volume":"138","author":"Meijers","year":"2018","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"Berk","year":"2007","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B28","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/HYPERTENSIONAHA.111.189258","article-title":"Blood pressure and risk of cancer incidence and mortality in the metabolic syndrome and cancer project","volume":"59","author":"Stocks","year":"2012","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B29","doi-asserted-by":"crossref","first-page":"e6394.","DOI":"10.1097\/MD.0000000000006394","article-title":"Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients? Evidence from a meta-analysis including 55 studies","volume":"96","author":"Sun","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B30","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.287.7.883","article-title":"beta-Blocker therapy in heart failure: scientific review","volume":"287","author":"Foody","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000455143","article-title":"Is beta-blocker use beneficial in breast cancer? A meta-analysis","volume":"92","author":"Kim","year":"2017","journal-title":"Oncology"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B32","doi-asserted-by":"crossref","first-page":"2911.","DOI":"10.1038\/s41598-017-02913-8","article-title":"Pre- and post-diagnostic \u03b2-blocker use and lung cancer survival: a population-based cohort study","volume":"7","author":"Weberpals","year":"2017","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4161\/cbt.10.1.11944","article-title":"\u03b22-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NF\u03baB and AP-1","volume":"10","author":"Zhang","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(97)80084-0","article-title":"Calcium-channel blockers and risk of cancer","volume":"349","author":"Jick","year":"1997","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0002-9343(99)00447-7","article-title":"Calcium channel blockers and cancer","volume":"108","author":"Cohen","year":"2000","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B36","doi-asserted-by":"crossref","first-page":"e009147.","DOI":"10.1136\/bmjopen-2015-009147","article-title":"Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD)","volume":"6","author":"Grimaldi-Bensouda","year":"2016","journal-title":"BMJ Open"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B37","doi-asserted-by":"crossref","first-page":"379252.","DOI":"10.1155\/2013\/379252","article-title":"Incidence of new-onset hypertension in cancer patients: a retrospective cohort study","volume":"2013","author":"Fraeman","year":"2013","journal-title":"Int J Hypertens"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11906-007-0058-7","article-title":"Chemotherapy agents and hypertension: a focus on angiogenesis blockade","volume":"9","author":"Jain","year":"2007","journal-title":"Curr Hypertens Rep"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B39","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cjca.2015.12.023","article-title":"Vascular complications of cancer chemotherapy","volume":"32","author":"Cameron","year":"2016","journal-title":"Can J Cardiol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B40","doi-asserted-by":"crossref","first-page":"68.","DOI":"10.1186\/1477-7819-4-68","article-title":"Distress, anxiety, and depression in cancer patients undergoing chemotherapy","volume":"4","author":"Pandey","year":"2006","journal-title":"World J Surg Oncol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B41","first-page":"1","article-title":"Effects of music therapy on anxiety, blood pressure and respiratory rate in patients undergoing chemotherapy","volume":"2","author":"Imran","year":"2017","journal-title":"Nurs Care Open Access J"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijcard.2017.10.035","article-title":"Heart failure and inflammation-related biomarkers as predictors of new-onset diabetes in the general population","volume":"250","author":"Suthahar","year":"2018","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B43","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B44","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B45","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B46","doi-asserted-by":"crossref","first-page":"g7607.","DOI":"10.1136\/bmj.g7607","article-title":"Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies","volume":"350","author":"Tsilidis","year":"2015","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B47","doi-asserted-by":"crossref","first-page":"703.","DOI":"10.1186\/s12885-017-3696-4","article-title":"Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy","volume":"17","author":"Ballotari","year":"2017","journal-title":"BMC Cancer"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B48","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nm.3596","article-title":"Overcoming drug development bottlenecks with repurposing: repurposing biguanides to target energy metabolism for cancer treatment","volume":"20","author":"Pollak","year":"2014","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B50","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1940-6207.CAPR-13-0424","article-title":"Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders","volume":"7","author":"Gandini","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B51","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1586\/17474124.2015.1089170","article-title":"Is obesity an advantage in patients with colorectal cancer?","volume":"9","author":"Kasi","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B52","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1634\/theoncologist.2009-0285","article-title":"Obesity and cancer","volume":"15","author":"Wolin","year":"2010","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B53","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2014viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B54","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B55","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/0008-5472.CAN-16-1916","article-title":"Hypercholesterolemia increases colorectal cancer incidence by reducing production of NKT and \u03b3\u03b4 T cells from hematopoietic stem cells","volume":"77","author":"Tie","year":"2017","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B56","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ajpath.2010.11.005","article-title":"Role of cholesterol in the development and progression of breast cancer","volume":"178","author":"Llaverias","year":"2011","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B57","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.ajpath.2014.03.006","article-title":"Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo","volume":"184","author":"Pelton","year":"2014","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The EuroHeart Failure Survey programme\u2014a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B59","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0140-6736(02)11601-1","article-title":"Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey","volume":"360","author":"Cleland","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B60","first-page":"1171","article-title":"Influence of sex on mortality in hospitalized patients with congestive heart failure and preserved or depressed systolic function","volume":"58","author":"Varela Rom\u00e9n","year":"2005","journal-title":"Rev Esp Cardiol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev Cell"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12013-011-9253-x","article-title":"Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-\u03b3 ligands via Wnt signaling pathway","volume":"62","author":"Liu","year":"2012","journal-title":"Cell Biochem Biophys"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B63","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1136370","article-title":"LRP6 mutation in a family with early coronary disease and metabolic risk factors","volume":"315","author":"Mani","year":"2007","journal-title":"Science"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B64","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1301824","article-title":"A form of the metabolic syndrome associated with mutations in DYRK1B","volume":"370","author":"Keramati","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B65","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.3390\/ijms14035560","article-title":"Mirk\/dyrk1B kinase in ovarian cancer","volume":"14","author":"Friedman","year":"2013","journal-title":"Int J Mol Sci"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B66","doi-asserted-by":"crossref","first-page":"116","DOI":"10.7326\/M18-0737","article-title":"Clonal hematopoiesis confers predisposition to both cardiovascular disease and cancer: a newly recognized link between two major killers","volume":"169","author":"Ebert","year":"2018","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B67","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B69","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B70","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"Freedman","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B71","doi-asserted-by":"crossref","first-page":"1505.","DOI":"10.1001\/jama.294.12.1505","article-title":"Effect of smoking reduction on lung cancer risk","volume":"294","author":"Godtfredsen","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B72","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.amjmed.2017.02.052","article-title":"Smoking status and incidence of cancer after myocardial infarction: a follow-up study of over 20 years","volume":"130","author":"Lotan","year":"2017","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B74","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10654-017-0231-5","article-title":"Myocardial infarction and future risk of cancer in the general population\u2014the Troms\u00f8 study","volume":"32","author":"Rinde","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B75","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2016.04.053","article-title":"Heart failure after myocardial infarction is associated with increased risk of cancer","volume":"68","author":"Hasin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B76","doi-asserted-by":"crossref","first-page":"e88639.","DOI":"10.1371\/journal.pone.0088639","article-title":"Reduction of death rate due to acute myocardial infarction in subjects with cancers through systemic restoration of impaired nitric oxide. Gaetano C, ed","volume":"9","author":"Ghosh","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B77","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/eurjhf\/hfq045","article-title":"Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European society of cardiology and endorsed by the European society of intensive care medicine","volume":"12","author":"Gheorghiade","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B78","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jhh.2008.131","article-title":"Diuretic use and the risk of breast cancer","volume":"23","author":"Coogan","year":"2009","journal-title":"J Hum Hypertens"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B79","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/sj.jhh.1002075","article-title":"Hypertension, diuretics and breast cancer risk","volume":"20","author":"Largent","year":"2006","journal-title":"J Hum Hypertens"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B80","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2017.11.042","article-title":"Hydrochlorothiazide use and risk of nonmelanoma skin cancer: a nationwide case-control study from Denmark","volume":"78","author":"Pedersen","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B81","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.ejca.2008.06.025","article-title":"Statins and cancer: a systematic review and meta-analysis","volume":"44","author":"Kuoppala","year":"2008","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B82","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1634\/theoncologist.11-3-306","article-title":"The role of statins in cancer therapy","volume":"11","author":"Hindler","year":"2006","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B83","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B84","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B85","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B86","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11912-013-0351-3","article-title":"Role of aspirin in cancer prevention","volume":"15","author":"Thorat","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B87","doi-asserted-by":"crossref","first-page":"83.","DOI":"10.1136\/bmj.310.6972.83","article-title":"United Kingdom prospective diabetes study (UKPDS). 13: relative Efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years","volume":"310","year":"1995","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B88","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1158\/1940-6207.CAPR-10-0055","article-title":"Metformin prevents tobacco carcinogen-induced lung tumorigenesis","volume":"3","author":"Memmott","year":"2010","journal-title":"Cancer Prev Res"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B89","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B90","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1634\/theoncologist.2011-0462","article-title":"Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis","volume":"17","author":"Soranna","year":"2012","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B91","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2337\/dc11-0512","article-title":"Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis","volume":"34","author":"Zhang","year":"2011","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B92","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1007\/s00125-017-4370-8","article-title":"SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials","volume":"60","author":"Tang","year":"2017","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B93","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/hrt.2006.098731","article-title":"Cardiac catheterisation: radiation doses and lifetime risk of malignancy","volume":"93","author":"Vijayalakshmi","year":"2007","journal-title":"Heart"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B94","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.hfc.2016.12.004","article-title":"Management of heart failure in cancer patients and cancer survivors","volume":"13","author":"Finet","year":"2017","journal-title":"Heart Fail Clin"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B95","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehx026","article-title":"Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study","volume":"38","author":"Ouwerkerk","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B96","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/hrt.2002.007005","article-title":"Inflammatory mediators in chronic heart failure: an overview","volume":"90","author":"Anker","year":"2004","journal-title":"Heart"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B97","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B98","doi-asserted-by":"crossref","first-page":"e003688.","DOI":"10.1161\/CIRCHEARTFAILURE.116.003688","article-title":"Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure","volume":"10","author":"Bansal","year":"2017","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B99","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1182\/blood-2010-07-299321","article-title":"Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL","volume":"117","author":"Christopoulos","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B100","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cvr\/cvu025","article-title":"Cardiac macrophages and their role in ischaemic heart disease","volume":"102","author":"Frantz","year":"2014","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B101","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B102","doi-asserted-by":"crossref","first-page":"1.","DOI":"10.1186\/2050-7771-2-1","article-title":"Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases","volume":"2","author":"Yang","year":"2014","journal-title":"Biomark Res"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B103","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2002-10-3228","article-title":"Rapid recruitment of inflammatory monocytes is independent of neutrophil migration","volume":"102","author":"Henderson","year":"2003","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B104","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B105","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B106","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.matbio.2018.01.013","article-title":"Extracellular matrix remodeling and cardiac fibrosis","volume":"68\u201369","author":"Li","year":"2018","journal-title":"Matrix Biol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B107","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/ejhf.312","article-title":"Searching for new mechanisms of myocardial fibrosis with diagnostic and\/or therapeutic potential","volume":"17","author":"Heymans","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B108","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.1406","article-title":"Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology","author":"de Boer","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B109","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B110","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.aao5801","article-title":"Obesity and the tumor microenvironment","volume":"358","author":"Olson","year":"2017","journal-title":"Science"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B111","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B112","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrclinonc.2011.83","article-title":"Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?","volume":"8","author":"De Bock","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B113","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/713773607","article-title":"The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities","volume":"10","author":"De Boer","year":"2003","journal-title":"Microcirculation"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B114","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/heart.88.4.412","article-title":"Identification of a specific pattern of downregulation in expression of isoforms of vascular endothelial growth factor in dilated cardiomyopathy","volume":"88","author":"De Boer","year":"2002","journal-title":"Heart"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B115","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/01.RES.87.8.644","article-title":"Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy","volume":"87","author":"Abraham","year":"2000","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B116","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/8374","article-title":"Therapeutic angiogenesis for heart failure","volume":"5","author":"Isner","year":"1999","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2013\/680536","article-title":"The association between obesity and cancer risk: a meta-analysis of observational studies from 1985 to 2011","volume":"2013","author":"Dobbins","year":"2013","journal-title":"ISRN Prev Med"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B118","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ejhf.1138","article-title":"The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC","volume":"20","author":"Frantz","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B119","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/cvr\/cvx130","article-title":"Insights into innate immune signalling in controlling cardiac remodelling","volume":"113","author":"Zhang","year":"2017","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrcardio.2015.169","article-title":"Regulatory T cells in cardiovascular diseases","volume":"13","author":"Meng","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B121","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCRESAHA.116.304072","article-title":"Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction","volume":"116","author":"Hofmann","year":"2015","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B122","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jacc.2015.02.034","article-title":"Imaging systemic inflammatory networks in ischemic heart disease","volume":"65","author":"Nahrendorf","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B123","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B124","doi-asserted-by":"crossref","first-page":"933.","DOI":"10.1016\/S0140-6736(18)30533-6","article-title":"Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis","volume":"391","author":"Moslehi","year":"2018","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B125","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"key\n\t\t\t\t2019040805011827200_cvz035-B126","doi-asserted-by":"crossref","first-page":"viii6","DOI":"10.1093\/annonc\/mds256","article-title":"Immuno-oncology: understanding the function and dysfunction of the immune system in cancer","volume":"23","author":"Finn","year":"2012","journal-title":"Ann Oncol"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/115\/5\/844\/28283336\/cvz035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T04:37:50Z","timestamp":1662871070000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/115\/5\/844\/5306334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":126,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,2,4]]},"published-print":{"date-parts":[[2019,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvz035","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4,15]]},"published":{"date-parts":[[2019,2,4]]}}}